Person looking off into the distance.

AFTER 2 OR MORE TYPES OF TREATMENT FOR FL,

BREYANZI® MAKES COMPLETE AND
LASTING REMISSION POSSIBLE

Home > Results With Breyanzi > FL

RECLAIM TOMORROW: ACHIEVE PROLONGED RESULTS WITH A ONE-TIME INFUSION*

Explore the clinical trial results below or view the potential side effects.

COMPLETE REMISSION IS POSSIBLE AFTER 2 OR MORE PRIOR TREATMENTS

Who was in this study and what were the results?

A clinical study evaluated 114 adult patients with follicular lymphoma (FL) that had come back or stopped responding to treatment after 2 or more other types of treatment.

96% of people had their cancer shrink or disappear
This is called overall response, which was seen in 90 out of 94 people and measures a decrease or disappearance of cancer in the body.
73% of people showed no signs of cancer
This is called complete response, which was seen in 69 out of 94 people. Complete response means there were no signs of cancer in the body, but it does not mean the cancer has been cured. 
The rest of the people who responded (21 out of 94 people, or 22%) experienced a decrease of cancer in the body. This is called partial response.
RAPID REMISSION WAS SEEN WITH SOME PEOPLE EXPERIENCING COMPLETE OR PARTIAL RESPONSE AROUND 1 MONTH

In the clinical study, complete response was seen around 3 months (median) after infusion. This ranged from 0.6 months to 18 months.

Lasting remission is within reach:

More than 3 in 4 people continued to respond after 18 months
This is called duration of response. Out of the 90 people who responded to treatment with Breyanzi, approximately 77% continued to respond after 18 months.

*The treatment process includes blood collection, CAR T-cell creation, administration, and side-effect monitoring. No maintenance therapy for the lymphoma is needed after Breyanzi as long as you are responding to treatment.

These are the results experienced by people in the Breyanzi clinical studies. Your results may be different. 

Mantle Cell Lymphoma Patient Brochure cover.

Get to know Breyanzi CAR T-cell therapy in detail.

Click the button below to download the patient brochure. It will help you understand the treatment process, clinical results, safety information, and more.


Bristol Myers Squibb® logo

© 2026 Juno Therapeutics, Inc., a Bristol Myers Squibb company. All Rights Reserved.

BREYANZI and the related logo are trademarks of Juno Therapeutics, Inc., a Bristol Myers Squibb company.



2009-US-2600076, 2009-US-2600074 05/26